Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05019495 · ClinicalTrials.gov registry record · NA
Optimizing Tobacco Treatment Delivery for People Living With HIV
A NA study of HIV and Smoking, Cigarette, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- NA
- Development phase
- 231
- Enrollment target
- 1
- Study location
NCT05019495: Recruiting NA study of HIV and Smoking, Cigarette, sponsored by Medical University of South Carolina.
NCT05019495 is a NA study of HIV and Smoking, Cigarette that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 231 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05019495, a NA study of HIV and Smoking, Cigarette, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- NA
- Development phase
- 231 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to conduct a randomized trial to evaluate a proactive, opt-out model of provider contact to deliver smoking cessation support for people living with HIV compared to standard care support delivered through traditional clinic pathways. Investigators will also evaluate implementation outcomes to identify barriers and facilitators towards future implementation. Investigators hope to define best practices and optimize the delivery of smoking cessation interventions for people living with HIV.
Primary Outcome
Self-reported and confirmed by breath carbon monoxide test
Conditions Studied
Interventions
- BEHAVIORAL PrOMOTE
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 231 participants |
| Start Date | 2021-12-01 |
| Est. Completion | 2027-02-28 |
| Phase | NA |
What NCT05019495 shows while recruiting
NCT05019495 is an interventional study that assigns participants to a tested intervention. The registered 231 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (47% lower).
The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which PrOMOTE is the first listed.
NCT05019495 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT05019495 about?
NCT05019495 is a clinical study titled "Optimizing Tobacco Treatment Delivery for People Living With HIV". The purpose of this study is to conduct a randomized trial to evaluate a proactive, opt-out model of provider contact to deliver smoking cessation support for people living with HIV compared to standard care support delivered through traditional clinic pathways. Investigators will also evaluate impl...
What is the current status of trial NCT05019495?
This trial is currently recruiting. It is a NA study. The enrollment target is 231 participants. The study started on 2021-12-01. Estimated completion is 2027-02-28.
What conditions does trial NCT05019495 study?
This clinical trial studies the following conditions: HIV, Smoking, Cigarette.
What interventions are being tested in trial NCT05019495?
The interventions under investigation include: PrOMOTE (BEHAVIORAL).
Who is sponsoring clinical trial NCT05019495?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05019495 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05019495's enrollment target sits among peer trials
231 92nd of 303 higher than 212 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04077099 · 231 participants · Phase 1
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
- NCT06023589 · 231 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- NCT06734351 · 231 participants · Phase 3
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
- NCT06749457 · 231 participants · Phase 1
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI